Catalysts for Alembic Pharmaceuticals Inc
165 tracked
Dec 16, 2025
approval
LOSARTAN POTASSIUM — FDA approval
Alembic Pharmaceuticals Inc
→
Dec 16, 2025
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
Alembic Pharmaceuticals Inc
→
Dec 10, 2025
approval
LOTEPREDNOL ETABONATE AND TOBRAMYCIN (LOTEPREDNOL ETABONATE) — FDA approval
loteprednol etabonate
→
Nov 26, 2025
recall
Alembic Pharmaceuticals Limited recall (Cls III)
Alembic Pharmaceuticals Inc
→
Nov 19, 2025
approval
ROPINIROLE HYDROCHLORIDE — FDA approval
ropinirole hydrochloride ER
→
Nov 14, 2025
approval
DILTIAZEM HYDROCHLORIDE — FDA approval
DILTIAZEM HYDROCHLORIDE
→
Nov 12, 2025
approval
DEXLANSOPRAZOLE — FDA approval
dexlansoprazole DR
→
Nov 6, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Nov 6, 2025
approval
DASATINIB — FDA approval
DASATINIB
→
Nov 6, 2025
approval
SUMATRIPTAN SUCCINATE — FDA approval
SUMATRIPTAN SUCCINATE
→
Oct 28, 2025
approval
TICAGRELOR — FDA approval
TICAGRELOR
→
Oct 17, 2025
approval
TRIAMCINOLONE ACETONIDE — FDA approval
triamcinolone acetonide Rising
→
Sep 29, 2025
approval
DESIPRAMINE HYDROCHLORIDE — FDA approval
DESIPRAMINE HYDROCHLORIDE
→
Sep 24, 2025
approval
TIZANIDINE HYDROCHLORIDE — FDA approval
TIZANIDINE HYDROCHLORIDE
→
Sep 24, 2025
approval
PAROXETINE HYDROCHLORIDE — FDA approval
PAROXETINE HYDROCHLORIDE
→
Aug 13, 2025
recall
Alembic Pharmaceuticals Limited recall (Cls II)
Alembic Pharmaceuticals Inc
→
Jul 25, 2025
approval
CARBAMAZEPINE — FDA approval
carbamazepine ER
→
Jun 18, 2025
recall
Alembic Pharmaceuticals Limited recall (Cls II)
Alembic Pharmaceuticals Inc
→
Jun 4, 2025
recall
Alembic Pharmaceuticals Limited recall (Cls II)
Alembic Pharmaceuticals Inc
→
May 23, 2025
approval
BOSUTINIB MONOHYDRATE — FDA approval
BOSUTINIB MONOHYDRATE
→
May 2, 2025
approval
TICAGRELOR — FDA approval
TICAGRELOR
→
May 1, 2025
device 510k
Alembic, LLC — APRO 45 Catheter (510k cleared)
Alembic Pharmaceuticals Inc
→
Apr 30, 2025
device 510k
Alembic, LLC — APRO 45 Catheter and Alembic Aspiration Tubing (510k cleared)
Alembic Pharmaceuticals Inc
→
Apr 29, 2025
device 510k
Alembic, LLC — APRO 55 Intermediate Catheter (510k cleared)
Alembic Pharmaceuticals Inc
→
Apr 28, 2025
device 510k
Alembic, LLC — APRO 55 Swift Catheter and Alembic Aspiration Tubing (510k cleared)
Alembic Pharmaceuticals Inc
→
Apr 16, 2025
approval
CARBAMAZEPINE — FDA approval
carbamazepine ER
→
Feb 24, 2025
device 510k
Alembic, LLC — APRO 70 Swift Catheter and Alembic Aspiration Tubing (510k cleared)
Alembic Pharmaceuticals Inc
→
Jan 29, 2025
approval
BUPROPION HYDROCHLORIDE — FDA approval
BUPROPION HYDROCHLORIDE
→
Jan 14, 2025
device 510k
Alembic, LLC — APRO 70 Swift Catheter (510k cleared)
Alembic Pharmaceuticals Inc
→
Dec 3, 2024
approval
BOSULIF (BOSUTINIB MONOHYDRATE) — FDA approval
Alembic Pharmaceuticals Inc
→